Accelerate Diagnostics
AXDX
#10564
Rank
HK$6.69 M
Marketcap
HK$0.26
Share price
0.00%
Change (1 day)
-97.83%
Change (1 year)

Revenue for Accelerate Diagnostics (AXDX)

Revenue in 2024 (TTM): HK$91.16 Million

According to Accelerate Diagnostics's latest financial reports the company's current revenue (TTM ) is HK$91.06 Million. a decrease over the revenue in the year 2023 that were of HK$94.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Accelerate Diagnostics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 HK$90.81 M-3.57%
2023 HK$94.18 M-5.47%
2022 HK$99.62 M8.45%
2021 HK$91.86 M6.14%
2020 HK$86.54 M19.53%
2019 HK$72.4 M63.07%
2018 HK$44.4 M36.09%
2017 HK$32.62 M1610.35%
2016 HK$1.9 M67.43%
2015 HK$1.13 M20.4%
2014 HK$0.94 M151.94%
2013 HK$0.37 M
2011 HK$4.28 M-81.4%
2010 HK$23.03 M343.23%
2009 HK$5.19 M-28.57%
2008 HK$7.27 M287.44%
2007 HK$1.87 M13.8%
2006 HK$1.65 M-44.17%
2005 HK$2.95 M-15523.96%
2004 -HK$0.02 Million-100.48%
2003 HK$4 M-33.03%
2002 HK$5.98 M47.54%
2001 HK$4.05 M-56.22%
2000 HK$9.27 M-51.61%
1999 HK$19.15 M-46.55%
1998 HK$35.84 M-20.72%
1997 HK$45.21 M154.16%
1996 HK$17.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Thermo Fisher Scientific
TMO
HK$340.45 B 373,767.33%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$26.13 B 28,601.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$166.47 B 182,717.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
HK$19.90 B 21,762.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
HK$1.26 B 1,288.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bruker
BRKR
HK$26.76 B 29,297.33%๐Ÿ‡บ๐Ÿ‡ธ USA